WELL Health Technologies (TSE:WELL) Price Target Cut to C$7.00 by Analysts at Scotiabank

WELL Health Technologies (TSE:WELL) had its target price trimmed by Scotiabank from C$8.00 to C$7.00 in a research report report published on Wednesday,BayStreet.CA reports. The firm currently has an outperform rating on the stock.

Other equities analysts have also issued research reports about the stock. Royal Bank of Canada lowered their price objective on shares of WELL Health Technologies from C$8.50 to C$7.50 and set an “outperform” rating for the company in a research report on Monday, March 31st. TD Securities dropped their price target on WELL Health Technologies from C$8.50 to C$7.50 and set a “buy” rating on the stock in a research report on Wednesday. CIBC lowered their price target on shares of WELL Health Technologies from C$7.00 to C$5.00 and set a “neutral” rating for the company in a research report on Wednesday. Raymond James lifted their price objective on shares of WELL Health Technologies from C$10.00 to C$11.00 in a report on Tuesday, December 17th. Finally, Ventum Financial lowered their target price on WELL Health Technologies from C$8.00 to C$7.60 and set a “buy” rating for the company in a report on Wednesday. One equities research analyst has rated the stock with a hold rating and five have given a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of C$8.08.

WELL Health Technologies Stock Down 3.2 %

Shares of WELL stock opened at C$3.91 on Wednesday. The stock has a market cap of C$977.20 million, a P/E ratio of 13.25, a PEG ratio of -1.93 and a beta of 1.20. The company’s fifty day simple moving average is C$5.15 and its two-hundred day simple moving average is C$5.55. The company has a quick ratio of 1.02, a current ratio of 1.14 and a debt-to-equity ratio of 46.79. WELL Health Technologies has a 52 week low of C$3.46 and a 52 week high of C$7.36.

WELL Health Technologies Company Profile

WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. It provides omni-channel patient services and solutions to specific markets, such as provider staffing, anesthesia, gastrointestinal health, women's health, primary care, and mental healthcare.